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Impaired mitochondrial function has been implicated
in the pathogenesis of type 2 diabetes, heart failure,
and neurodegeneration as well as during aging.
Studies with the PGC-1 transcriptional coactivators
have demonstrated that these factors are central
components of the regulatory network that controls
mitochondrial function in mammalian cells. Here we
describe a genome-wide coactivation assay to glob-
ally identify transcription factors and cofactors in this
pathway. These analyses revealed a molecular sig-
nature of the PGC-1a transcriptional network and
identified BAF60a (SMARCD1) as a molecular link
between the SWI/SNF chromatin-remodeling com-
plexes and hepatic lipid metabolism. Adenoviral-
mediated expression of BAF60a stimulates fatty
acid b-oxidation in cultured hepatocytes and amelio-
rates hepatic steatosis in vivo. PGC-1amediates the
recruitment of BAF60a to PPARa-binding sites, lead-
ing to transcriptional activation of peroxisomal and
mitochondrial fat-oxidation genes. These results de-
fine a role for the SWI/SNF complexes in the regula-
tion of lipid homeostasis.
INTRODUCTION
Metabolic syndrome is emerging as a global epidemic and is
characterized by a clustering of several disorders, including obe-
sity, type 2 diabetes, fatty liver, and dyslipidemia (Flier, 2004;
Zimmet et al., 2001). Ectopic accumulation of triglycerides (TG)
in the liver is an early pathogenic event in the development of
nonalcoholic steatohepatitis (NASH), which is characterized by
chronic inflammation and liver damage. Hepatic steatosis also
contributes to the pathogenesis of insulin resistance and influ-
ences systemic glucose metabolism. The liver regulates several
major aspects of lipid metabolism, including lipogenesis, fatty
acid b-oxidation (FAO), as well as lipoprotein uptake and secre-
tion. These pathways are under the control of nutritional and hor-
monal signals to maintain hepatic and systemic fuel homeosta-
sis. In particular, hepatic fat oxidation is enhanced in the fasted
state as a result of increased availability of fatty acids and theCtranscriptional activation of genes involved in peroxisomal and
mitochondrial FAO (Eaton, 2002; Reddy and Hashimoto, 2001).
The transcriptional regulatory networks comprise transcription
factors (TFs) and cofactors that are stably or transiently assem-
bled into multiprotein complexes. These physical interactions
form the basis for robust yet highly dynamic networks that con-
trol gene expression. Recent studies have demonstrated that
transcriptional coactivators play an important role in the regula-
tion of diverse biological programs, including mitochondrial oxi-
dative phosphorylation (OXPHOS), smooth-muscle differentia-
tion, and B cell development (Christian et al., 2006; Feige and
Auwerx, 2007; Spiegelman and Heinrich, 2004). PPARg coacti-
vator-1a (PGC-1a) is an inducible coactivator for nuclear hor-
mone receptors and other TFs and belongs to a small family of
coactivators that includes PGC-1b and PGC-1-related coactiva-
tor (Finck and Kelly, 2006; Lin et al., 2005a). PGC-1a regulates
several major metabolic pathways, including mitochondrial OX-
PHOS (Lehman et al., 2000; St-Pierre et al., 2003; Wu et al.,
1999), hepatic gluconeogenesis (Herzig et al., 2001; Yoon
et al., 2001), and reactive oxygen species metabolism (St-Pierre
et al., 2006; Valle et al., 2005). This factor also regulates circa-
dian-clock function, slow-twitch muscle-fiber formation, and
heme homeostasis (Handschin et al., 2005; Lin et al., 2002; Liu
et al., 2007). Mice deficient in PGC-1a have impaired mitochon-
drial function in several tissues and develop spongiform neuro-
degeneration (Leone et al., 2005; Lin et al., 2004). These obser-
vations suggest that PGC-1a is a key component of the
transcriptional regulatory network that maintains energy homeo-
stasis in mammals.
PGC-1a exerts its effects on gene expression through recruit-
ing chromatin-remodeling complexes to its transcriptional part-
ners, leading to a switch in chromatin structure to an active state.
Although several TFs and cofactors have been found to mediate
the effects of PGC-1a on energy metabolism, a comprehensive
list of transcriptional partners for PGC-1a remains not available.
We therefore reasoned that global identification of transcrip-
tional partners for PGC-1a would reveal the architecture of an
important metabolic regulatory network. The present studies
were undertaken to develop a genome-wide high-throughput
coactivation screen and to examine the biological role of PGC-
1a partners in metabolic regulation. Our analyses revealed
a set of TFs and cofactors that physically interact with PGC-1a
and identified BAF60a as a key regulator of hepatic lipid
homeostasis.ell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc. 105
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BAF60a Regulates Hepatic Fat OxidationFigure 1. Identification of Transcriptional Partners for PGC-1a through Genome-wide Coactivation Screen
(A) Schematic diagram of high-throughput coactivation screen of PGC-1a.
(B) Log-transformed fold coactivation by PGC-1a for individual Gal-TF clones. The red line denotes a 10-fold increase in luciferase activity by PGC-1a.
(C) Representative graphs of coIP between PGC-1a and 11 putative TF partners. Immunoblotting was performed on total lysates and immunoprecipitated
complexes from BOSC cells transiently transfected with Myc-TF (with pcDNA3 vector or Flag-PGC-1a).
(D) Schematic diagram of the PGC-1a transcriptional regulatory network. Previously reported (green line) and new factors identified in this study (red line) are
indicated.RESULTS
Identification of Transcriptional Partners for PGC-1a
through Genome-wide Coactivation Screen
PGC-1a stimulates the transcriptional activity of its cognate TF
partners when they are fused to a heterologous DNA-binding do-
main, such as the Gal4 DNA-binding domain (GalDBD) (Knutti
et al., 2000; Vega et al., 2000), suggesting that a coactivation
screen based on this reporter system could uncover biologically
relevant TF partners for PGC-1a. To develop a platform for a ge-
nome-wide coactivation assay, we first compiled a nonredun-
dant list of human TF and cofactor genes based on three recent
studies on global TF identification (Gray et al., 2004; Kanamori
et al., 2004; Kummerfeld and Teichmann, 2006) (see Table S1
online). This list includes 2,385 genes encoding DNA-binding
proteins and transcriptional cofactors. Among them, 1,146 are
present in the Human ORFeome v3.1, a collection of over
12,212 sequence-validated ORF clones in Gateway vector (La-
mesch et al., 2007; Walhout et al., 2000). We arrayed the ORF106 Cell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc.clones encoding these transcriptional regulators in 96 well plates
to generate a Transcription Factor ORF Collection (TFORC),
which covers 48% of all predicted TFs and cofactors in the hu-
man genome. TFORC contains all major classes of transcrip-
tional regulators that closely mirror their representation in the
genome (Table S2).
We next fused each of the 1,146 TF ORFs to the GalDBD vec-
tor using the Gateway cloning system to generate Gal-TF plas-
mids for coactivation studies. BOSC cells seeded in 96 well
plates were transiently transfected with UAS-luciferase and indi-
vidual Gal-TF plasmids in the presence or absence of PGC-1a
(Figure 1A). This cell line has been used for assaying coactivation
of TFs by PGC-1a in previous studies and is suitable for high-
throughput reporter assays because of high-transfection effi-
ciency (Handschin et al., 2007; Yoon et al., 2001). Independent
transfection experiments using Gal-TF from the same plate indi-
cate that although absolute luciferase values vary among exper-
iments, fold coactivation by PGC-1a for individual factors is
remarkably consistent (data not shown). We identified 40 factors
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more than 10-fold in these coactivation reporter assays (Fig-
ure 1B). PGC-1a exerts its effects on TFs and cofactors through
physical interactions. As such, we performed coimmunoprecipi-
tation (coIP) studies as a secondary screen to identify bona fide
partners for PGC-1a (Figure 1C). A total of 35 TFs and cofactors
scored positive in both coactivation and coIP assays, including
10 factors previously reported to function in concert with PGC-
1a (Figure 1D). The lack of physical interaction for several candi-
date factors is likely due to low levels of fusion-protein expres-
sion and/or the transient nature of interactions that may be lost
during immunoprecipitation. The identification of known PGC-
1a targets (Figure 1D, green edges) validates our approach
and suggests that many of the newly identified factors are likely
biologically relevant partners for PGC-1a.
Among the factors coactivated by PGC-1a are seven nuclear
hormone receptors, including estrogen-receptor-related recep-
tor a (ERRa), ERRg, RAR-related orphan receptor a (RORa)
and RORg. ERRa and ERRg have been demonstrated to regu-
late the expression of nuclear-encoded mitochondrial genes
(Huss et al., 2002; Mootha et al., 2004; Schreiber et al., 2004),
whereas RORa mediates the effects of PGC-1a on metabolic
and clock-gene expression (Lau et al., 2004; Liu et al., 2007).
In addition to nuclear receptors, PGC-1a interacts with 15
zinc-finger proteins, whose biological function remains largely
unknown. PGC-1a is known to recruit other chromatin-remodel-
ing proteins, including histone acetyltransferase (CBP/p300 and
GCN5) and deacetylase complexes (Lerin et al., 2006; Puig-
server et al., 1999; Rodgers et al., 2005). Several factors impli-
cated in chromatin remodeling were uncovered in our screen, in-
cluding host cell factor C1 (HCFC1) and BRG1-associated factor
60a (BAF60a). HCFC1 has been demonstrated to associate with
histone methyltransferase (Wysocka et al., 2003), while BAF60a
is a subunit of the SWI/SNF nucleosome-remodeling complexes
(Wang et al., 1996). Together, these results suggest that PGC-1a
may exert diverse effects on chromatin structure through nucle-
osome remodeling and histone modifications.
BAF60a Induces Peroxisomal and Mitochondrial FAO
Genes
To explore the biological activities of these PGC-1a partners in
regulating glucose and lipid metabolism, we generated 19 re-
combinant adenoviruses each expressing a different TF. We
transduced cultured primary hepatocytes with adenoviruses ex-
pressing GFP, PGC-1a, or individual factors and perform quan-
titative real-time PCR (qPCR) analyses to examine their effects
on known PGC-1a target genes (see the list in Table S3). As ex-
pected, PGC-1a strongly induces mRNA expression of genes
involved in fatty acid b-oxidation, mitochondrial OXPHOS, glu-
coneogenesis, and clock function (Figure S1). Clustering analy-
sis of the expression data indicates that BAF60a and PGC-1a
have nearly identical activities in the induction of this set of genes
(Figure 2A), whereas other factors examined have modest ef-
fects. BAF60a is a subunit of the SWI/SNF complexes, which
comprise a core ATPase (BRG1 or BRM) and several BRG1-
associated factors (BAF), including BAF170, BAF155, BAF60,
BAF57, and BAF53a (Martens and Winston, 2003; Wang et al.,
1996). The SWI/SNF complexes regulate the transcription of tar-
get genes through binding to specific TFs and altering local chro-Cmatin structure. Recent studies have implicated the BAF60
family members, including BAF60a, BAF60b, and BAF60c, in
mediating the interaction between the SWI/SNF complexes and
target TFs. For example, BAF60a interacts with glucocorticoid
receptor (GR) and c-Jun (Hsiao et al., 2003; Ito et al., 2001),
whereas BAF60c binds to several nuclear receptors, including
PPARg, estrogen receptor a (ERa) and RORa (Debril et al.,
2004). BAF60a mRNA is present in several tissues where PGC-
1a is also expressed, including brain, skeletal muscle, and the
liver (data not shown).While BAF60c plays a role in the regulation
of heart development and muscle differentiation (Lickert et al.,
2004; Simone et al., 2004), the biological function of BAF60a
remains largely unknown.
Further analyses indicate that BAF60a induces the expression
of genes involved in peroxisomal fatty acid b-oxidation in a dose-
dependent manner, including acetyl-Coenzyme A acyltransfer-
ase 1B (Acaa1b), palmitoyl acyl-Coenzyme A oxidase 1
(Acox1), L-bifunctional enzyme (Ehhadh), and enoyl-Coenzyme
A hydratase 1 (Ech1) (Figure 2B). BAF60a also induces the ex-
pression of mitochondrial FAO genes, such as carnitine palmi-
toyl-CoA transferase 1 (Cpt1a), acetyl-CoA acyltransferase 2
(Acaa2), and hydroxyacyl-CoA dehydrogenase (Hadha). Com-
pared to control, the expression of several nuclear-encoded mi-
tochondrial genes, such as superoxide dismutase 2 (SOD2) and
subunits of the electron transport chain, is also increased by
BAF60a. In contrast, the mRNA levels of fatty acid synthase
(FAS) and apolipoprotein B (ApoB) remain similar in transduced
hepatocytes, suggesting that BAF60a exerts specific effects on
downstream target genes. Similar to PGC-1a, BAF60a increases
mitochondrial DNA content and the expression levels of several
proteins of the respiratory complexes (Figures 2C and 2D).
To determine whether BAF60a enhances fatty acid b-oxidation,
we incubated transduced hepatocytes in the presence of
3H-labeled palmitate and measured 3H2O release. Consistent
with gene-expression data, adenoviral-mediated expression of
BAF60a dose dependently increases fat-oxidation rate
(Figure 2E). In contrast, BAF60a does not alter the secretion of
TG-containing lipoproteins in transduced primary hepatocytes
(Figure 2F).
BAF60a Reduces Liver Triglycerides in High-Fat Fed
Mice
Fatty acid b-oxidation is an important component of hepatic lipid
homeostasis. Hepatic steatosis results from imbalance of fat
availability and clearance in the liver and contributes to the path-
ogenesis of insulin resistance and NASH in obesity. Because
BAF60a stimulates FAO-gene expression and fat oxidation in
hepatocytes, it is possible that this factor may regulate hepatic
TG content through affecting lipid catabolism. To determine
the function of BAF60a in vivo, we transduced high-fat fed obese
mice with GFP or BAF60a adenoviruses through tail-vein injec-
tion. Immunoblotting analysis of nuclear extracts from trans-
duced livers indicates that BAF60a protein levels were elevated
by an approximately 3- to 5-fold over the endogenous levels
(Figure 3A). The protein levels of BRG1, BAF53a, PGC-1a, and
PPARa remain similar in both groups. Livers from BAF60a-trans-
duced mice appear red and are smaller than those from control
mice (Figure 3B). In fact, liver weight-to-body weight ratio is
reduced by approximately 18% in BAF60a-transduced mice.ell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc. 107
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BAF60a Regulates Hepatic Fat OxidationFigure 2. Regulation of Fatty Acid b-oxidation by BAF60a in Primary Hepatocytes
(A) Clustering analysis of gene expression in primary hepatocytes transduced with adenoviruses expressing GFP, PGC-1a, or individual TFs. Relative mRNA
expression of genes involved in hepatic gluconeogenesis, fatty acid b-oxidation, mitochondrial OXPHOS, and circadian clock were analyzed using qPCR.
(B) qPCR analysis of gene expression in hepatocytes transduced with GFP (open) or BAF60a adenoviruses at multiplicity of infection of 1 (gray) or 3 (filled).
(C) qPCR analysis of relative mitochondrial/nuclear DNA content.
(D) Immunoblotting analysis of transduced primary hepatocytes.
(E and F) Relative rate of fatty acid oxidation (E) and secretion of TG-containing lipoproteins (F) in transduced hepatocytes. All data represent mean ± SD;
*p < 0.05.Measurement of total hepatic TG content indicates that BAF60a
expression leads to 45% decrease in TG (Figure 3C). Consistent
with these results, lipid droplets are significantly smaller in the
livers expressing BAF60a, as revealed by Oil Red O and H&E
staining. Similar effects on hepatic TG content were also ob-
served in ob/ob mice transduced with BAF60a adenovirus
(data not shown).
To rule out the possibility that BAF60a may lower liver TG
through stimulation of lipoprotein secretion, we measured the
concentrations of plasma TG and nonesterified fatty acids in
transduced mice. Compared to GFP control mice, BAF60a
lowers plasma TG and fatty acid concentrations by 29% and
20% in high-fat fed mice, respectively (Figure 3C). Blood-glu-
cose levels are slightly increased in response to BAF60a. To di-
rectly measure the rate of very low-density lipoptrotein (VLDL)
secretion, we injected tyloxapol, an inhibitor of plasma lipases,
into transduced mice and measured the increase in plasma TG
concentrations. No significant difference in VLDL secretion
was observed (Figure 3D). Consistently, BAF60a had a modest108 Cell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc.effect on the expression of genes involved in lipoprotein metab-
olism, including apolipoprotein (apo) AV, apoB, and apoCIII. In
contrast, BAF60a significantly increases mRNA expression of
genes involved in peroxisomal and mitochondrial fatty acid oxi-
dation (Figure 3E). ThemRNA levels of PEPCK remain unaffected
by BAF60a. Taken together, our results strongly suggest that
BAF60a ameliorates hepatic steatosis through activation of
fatty acid oxidation.
Role of PGC-1a in the Induction of FAOGenes byBAF60a
BAF60a is a core subunit of the SWI/SNF chromatin-remodeling
complexes that activate or repress the transcription of diverse
target genes. Our studies indicate that BAF60a and PGC-1a
physically interact in the cell (Figure 1C). The surprisingly specific
transcriptional effects of BAF60a raise the possibility that it may
regulate FAO gene expression through directing the SWI/SNF
complexes to PGC-1a. To further determine whether PGC-1a
associates with endogenous BAF60a and other SWI/SNF
subunits, we performed coIP assays in BOSC cells transiently
Cell Metabolism
BAF60a Regulates Hepatic Fat OxidationFigure 3. Adenoviral-Mediated Expression of BAF60a Lowers Hepatic TG Content
(A) Immunoblots of liver nuclear extracts from transduced mice using indicated antibodies. The expression of endogenous (En-BAF60a) and adenoviral
(Ad-BAF60a) BAF60a proteins is indicated.
(B) Liver morphology and histological staining of liver sections from mice 6 days after tail-vein injection.
(C) Liver TG, plasma lipid, and glucose concentrations in mice transduced with GFP or BAF60a adenoviruses.
(D) Increase in plasma TG following intravenous injection of tyloxapol (500mg/kg) inmice transducedwith GFP (open circle) or BAF60a (filled circle) adenoviruses.
(E) qPCR analysis of hepatic gene expression in mice transduced with GFP (open) or BAF60a (filled) adenoviruses. Data in (C–E) represent mean ± SEM, n = 5;
*p < 0.05.transfected with Flag-tagged PGC-1a. We found that, in addition
to BAF60a, PGC-1a is also associated with BRG1 and BAF53a
(Figure 4A). The presence of BAF53a in the PGC-1a protein com-
plex was also observed in previous affinity purification studies
(Lerin et al., 2006). CoIP experiments with liver nuclear extracts
indicate that BAF60a associates with PGC-1a in vivo (Figure 4B).
Additionally, confocal microscopy studies revealed that PGC-1a
and BAF60a colocalize to nuclear speckles as well as to the
nucleoplasm in the cell (Figure 4C).
We next examined whether BAF60a and PGC-1a functionally
interact in the induction of FAO genes in hepatocytes. While both
BAF60a and PGC-1a increase mRNA levels of several FAO
genes—including Acaa1b, Acox1, and Hadha—simultaneous
expression of these two factors leads to significantly higher in-
duction of target genes (Figure 4D). To determine whether
PGC-1a is required for the induction of FAO genes by BAF60a,
we isolated primary hepatocytes from wild-type and PGC-
1a-null mice and transduced these hepatocytes with GFP or
BAF60a adenoviruses. qPCR analysis indicates that BAF60a in-
creases FAO-gene expression in both genotypes. However, the
stimulatory effect of BAF60a on these genes is significantlyCblunted in hepatocytes lacking PGC-1a (Figure 4E). Further-
more, the increase in fat oxidation in response to BAF60a is
significantly reduced in PGC-1a- null hepatocytes (Figure 4F).
Consistent with these findings, BAF60a induction of FAO genes
is also diminished in PGC-1a-null mouse livers (Figure 4G). We
conclude from these studies that PGC-1a is necessary for
the normal function of BAF60a in the regulation of FAO-gene
expression and fat oxidation.
Crosstalk between BAF60a and PPARa
Transcriptional activation of peroxisomal and mitochondrial fat-
oxidation genes by BAF60a is reminiscent of PPARa activation.
Previous studies have demonstrated that PPARa is a key tran-
scriptional regulator of FAO genes and is essential for hepatic
fat oxidation during starvation (Hashimoto et al., 2000; Kersten
et al., 1999). In addition, PGC-1a physically interacts with PPARa
and augments its transcriptional activity (Vega et al., 2000). To
determine whether BAF60a and PPARa cooperatively regulate
FAO genes, we treated transduced hepatocytes with vehicle
(DMSO) or Wy14,643, a synthetic agonist for PPARa. Gene-
expression analysis indicates that the induction of Acaa1b,ell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc. 109
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BAF60a Regulates Hepatic Fat OxidationFigure 4. Physical and Functional Interaction between BAF60a and PGC-1a
(A) Immunoblots of total lysates or immunoprecipitated proteins fromBOSC cells transiently transfectedwith pcDNA3 vector or Flag-PGC-1a plasmids. Note that
PGC-1a associates with endogenous BAF60a, BRG-1, and BAF53a.
(B) Immunoblots of precipitated liver nuclear complexes using IgG and PGC-1a antibodies.
(C) Confocal microscopy images of H2.35 hepatoma cells transiently transfected with GFP-PGC-1a and RFP-BAF60a plasmids.
(D) qPCR analysis of gene expression in primary hepatocytes transduced with adenoviruses expressing GFP, BAF60a, PGC-1a, or the combination of BAF60a
and PGC-1a. Data represent mean ± SD; *p < 0.01.
(E) qPCR analysis of gene expression in wild-type (filled) and PGC-1a-null (open) hepatocytes transduced with GFP or BAF60a adenoviruses, as indicated.
(F) FAO rate in transduced hepatocytes isolated from wild-type (filled) and PGC-1a-null (open) mice.
(G) qPCR analysis of gene expression in wild-type (filled) and PGC-1a-null (open) mouse livers transduced with GFP or BAF60a adenoviruses. Data in (E–G)
represent mean ± SD; *p < 0.05 WT versus PGC-1a null.Acox1, and Hadha by BAF60a is significantly augmented in the
presence of Wy14,643 (Figure 5A), suggesting that BAF60a
and PPARa functionally crosstalk in the regulation of FAO-
gene transcription. Previous transcriptional profiling studies
have demonstrated that Wy14,643 induces the expression of
many peroxisomal and mitochondrial fat-oxidation genes in
cultured hepatocytes (Gene Expression Omnibus dataset
GSE8302). To determine the extent to which BAF60a regulates
the expression of PPARa target genes, we performedmicroarray
analysis on primary hepatocytes transduced with GFP or
BAF60a adenoviruses. Analysis of these datasets reveals that
PPARa and BAF60a induce the expression of 51 and 42 FAO
genes by more than 1.6-fold, respectively (Figure 5B). Among110 Cell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc.these, 35 FAO genes are induced by both factors (see the list
in Table S4), suggesting that they likely function in a common
transcriptional pathway.
BAF60a has been reported to bind to nuclear receptors and
other transcription factors; however, whether BAF60a interacts
with PPARa remains unknown. To test this possibility, we exam-
ined physical association between BAF60a and PPARa in the
liver. CoIP studies indicate that these two factors are present
in common protein complexes (Figure 5C). By incubating in vitro
transcribed and translated Flag-BAF60a with glutathione-S-
transferase (GST)-PPARa fusion protein, we found that PPARa
binds to BAF60a in the absence of Wy14,643, in contrast to its
ligand-dependent interaction with PGC-1a (Figure 5D) (Vega
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BAF60a Regulates Hepatic Fat OxidationFigure 5. Crosstalk between PPARa and BAF60a in the Regulation of Hepatic Fat Oxidation
(A) qPCR analysis of gene expression in hepatocytes transduced with GFP or BAF60a adenoviruses followed by vehicle () or 10 mMWy14,643 (+) treatments.
Data represent mean ± SD; *p < 0.05 Wy14,643 versus vehicle.
(B) Venn-diagram representation of FAO genes that are induced more than 1.6-fold by BAF60a or Wy14,643 treatment in hepatocytes.
(C) Immunoblots of precipitated liver nuclear complexes using IgG and PPARa antibodies.
(D) Immunoblots of Flag-tagged BAF60a and PGC-1a. GST-PPARa fusion protein was incubated with in vitro transcribed and translated Flag-BAF60a or
Flag-PGC-1a in the absence or presence of 20 mM Wy14,643.
(E) Immunoblots of Flag-tagged full-length (FL) or truncated PPARa proteins. Recombinant GST, GST-PGC-1a (1–400), or GST-BAF60a proteins were incubated
with in vitro transcribed and translated PPARa followed by immunoblotting analysis.
(F) Immunoblots of Flag-tagged BAF60a and PPARa. GST fusion proteins containing various domains of PGC-1a were incubated with in vitro transcribed and
translated Flag-BAF60a or Flag-PPARa followed by immunoblotting analysis.
(G) Immunoblots of Flag-tagged PPARa and PGC-1a. GST fusion proteins containing various domains of BAF60a were incubated with in vitro transcribed and
translated Flag-PPARa or Flag-PGC-1a followed by immunoblotting analysis.
(H) qPCR analysis of gene expression in wild-type (filled) or PPARa-null (open) hepatocytes transduced with GFP or BAF60a adenoviruses, as indicated. Data
represent mean ± SD; *p < 0.05 WT versus PPARa null.
(I) qPCR analysis of gene expression in wild-type (filled) or PPARa-null (open) mouse livers transduced with GFP or BAF60a adenoviruses. Data represent mean ±
SD; *p < 0.05 WT versus PPARa null.et al., 2000). Consistent with this observation, while PGC-1a fails
to interact with PPARa lacking AF2 domain (aa 1–450), BAF60a
associates with PPARa,even when the ligand binding and AF2
domains are deleted (aa 1–173) (Figure 5E)—suggesting that
PGC-1a and BAF60a interact with PPARa through distinct do-
mains. As expected, the N terminus of PGC-1a (aa 1–180), which
contains conserved LXXLL motifs for docking nuclear receptors,
is sufficient for binding PPARa. However, this domain fails to
bind BAF60a (Figure 5F). On the contrary, a region between
amino acids 180–560 of PGC-1a appears to interact withCBAF60a. While BAF60a contains two canonical LXXLL motifs
(aa 301–305 and 361–365), they appear to be dispensable for
its interaction with PPARa and PGC-1a (Figure 5G). Instead, in
vitro protein interaction assays demonstrate that PGC-1a and
PPARa binding involves a region located within aa 123–255 of
BAF60a. The exact protein interaction surface for PGC-1a and
PPARa within this region is currently unknown.
To determine whether PPARa is required for the induction of
FAO genes by BAF60a, we transduced wild-type and PPARa-
null primary hepatocytes with GFP or BAF60a adenoviruses.ell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc. 111
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BAF60a Regulates Hepatic Fat OxidationFigure 6. Recruitment of BAF60a to FAO Genes Is Induced by Fasting
(A) ChIP assay using BAF60a or AcH3 antibodies in H2.35 cells transduced with GFP or PGC-1a adenoviruses. PCR primers flanking PPRE present in the
promoters of Acaa1b, Acox1, and Hadha were used.
(B) qPCR analysis of BAF60a, PGC-1a, and PPARa expression in fed (open), fasted (24 hr, filled), and fasted/refed (24 hr/20 hr, gray) mouse livers. Data represent
mean ± SEM, n = 4; *p < 0.05.
(C) Immunoblots of liver nuclear extracts using indicated antibodies.
(D) ChIP assays with chromatin extracts prepared from fed, fasted, and refed mouse livers using indicated antibodies. PCR primers are the same as in (A).
(E) ChIP-qPCR assay with chromatin lysates prepared from 24 hr fasted wild-type (filled) or PGC-1a-null (open) mouse livers using BAF60a antibody. Data
represent mean ± SD, *p < 0.01 wild-type versus PGC-1a null.Gene-expression analysis indicates that BAF60a robustly in-
creases the expression of Acaa1b and Acox1 in wild-type hepa-
tocytes (Figure 5H). In contrast, the induction of these genes is
significantly blunted, but not abolished, in PPARa-deficient cells.
Similar findings were observed when transduced hepatocytes
were treated with Wy14,643. We next examined the effect of
BAF60a on FAO gene expression in wild-type and PPARa-null
mouse livers following adenoviral transduction. Compared with
wild-type control, the induction of Acaa1b and Acox1 (but not
Hadha) in response to BAF60a is significantly impaired in
PPARa-null mouse livers (Figure 5I). These results indicate that
PPARa is a key transcription factor that mediates the induction
of some—but not all—FAO genes by BAF60a.
PGC-1a Augments the Recruitment of BAF60a
to PPARa-Binding Sites
PGC-1a has been previously demonstrated to interact with and
coactivate PPARa in FAO gene regulation (Finck et al., 2006;
Vega et al., 2000). As described above, PGC-1a interacts with
endogenous BAF60a and other subunits of the SWI/SNF com-
plexes. To determine whether PGC-1a enhances the recruitment
of BAF60a to the PPARa- binding sites (PPREs), we performed
chromatin immunoprecipitation (ChIP) assays in H2.35 mouse
hepatoma cells transduced with GFP or PGC-1a adenoviruses.112 Cell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc.As expected, PGC-1a increases acetyl histone H3 levels in the
proximity of PPREs present on Acaa1b, Acox1, and Hadha
gene promoters in H2.35 hepatoma cells (Figure 6A). Compared
to GFP control, the association of endogenous BAF60a with
these regulatory regions is significantly enhanced by adenovi-
ral-mediated expression of PGC-1a. These results are consis-
tent with protein-protein interaction data and suggest that
PGC-1amay promote the formation of activating transcriptional
complexes that include PPARa, PGC-1a, and BAF60a on the
FAO promoters.
The induction of hepatic fat oxidation is an important aspect of
metabolic adaptation in the liver in response to starvation. The
increase in fat oxidation in the fasting state is accompanied by
transcriptional activation of peroxisomal and mitochondrial
FAO genes. To determine whether BAF60a expression is regu-
lated by nutritional status, we examined its mRNA and protein
levels in the livers from fed, fasted, or fasted/refed mice. As ex-
pected, mRNA levels of PPARa and PGC-1a are increased in the
liver during fasting (Figure 6B). To our surprise, BAF60a mRNA
expression remains largely unchanged under these feeding con-
ditions. Immunoblotting analyses of liver nuclear extracts indi-
cate that PGC-1a protein level is increased in the fasted liver,
while endogenous BAF60a protein levels are not altered by star-
vation (Figure 6C). In addition, protein levels of other subunits of
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and BAF53a, remain similar in all feeding conditions.
Because PGC-1a enhances the recruitment of BAF60a to the
PPARa-binding sites on the promoters of FAO genes, we next
examined whether the recruitment of BAF60a to PPREs is regu-
lated by feeding status. We performed ChIP assays using chro-
matin extracts from fed, fasted, or fasted/refed mouse livers.
Compared to the fed mice, the association of BAF60a with
Acaa1b, Acox1, and Hadha promoters is significantly increased
following 24 hr or 40 hr fasting (Figure 6D). Upon refeeding,
BAF60a dissociates from each of these promoters. Fasting-in-
duced recruitment of BAF60a occurs concomitantly with en-
hanced association of PPARa and PGC-1awith these chromatin
loci. In addition, the levels of acetylated histone are also elevated
in the fasted livers, coinciding with the induction of these genes.
To determine whether PGC-1a is required for the recruitment of
BAF60a during starvation, we performed ChIP assays in wild-
type and PGC-1a-null mouse livers following 24 hr fasting.
ChIP-qPCR analysis of promoter occupancy by BAF60a indi-
cates that the recruitment of BAF60a to FAO gene promoters
is significantly impaired in PGC-1a-null livers (Figure 6E). These
data are consistent with a role for PGC-1a in mediating the
recruitment of BAF60a to its target chromatin loci in the liver.
BAF60a Is Required for Hepatic Fat Oxidation During
Starvation
Fasting-induced association of BAF60a with FAO gene pro-
moters suggests that it may participate in the formation of tran-
scriptional complexes that induce the expression of FAO genes
during starvation. To determine whether BAF60a is required for
FAO gene expression and fat oxidation in vivo, we performed
RNAi knockdown in the liver using a recombinant adenovirus ex-
pressing shRNA directed toward BAF60a. Mice were fasted for
40 hr 2 days after tail-vein transduction. Immunoblotting analy-
ses of liver nuclear extracts indicate that BAF60a protein levels
are significantly decreased following the injection of RNAi ade-
novirus (Figure 7A). The expression of BRG1, BAF53a, PGC-1a,
and PPARa is only modestly affected. The animals appear nor-
mal; however, the livers from mice receiving RNAi adenovirus
are significantly enlarged (0.97 ± 0.02 g control versus 1.14 ±
0.05 g RNAi; mean ± SEM, p < 0.01) and appear light yellow,
characteristic of hepatic steatosis (Figure 7B). Measurements
of hepatic lipids indicate that reduced expression of BAF60a re-
sults in approximately 2-fold increase of TG content compared
to control (Figure 7C). In addition, Oil Red O staining of liver sec-
tions revealed significantly larger fat droplets in the BAF60a-
deficient mice. Although plasma glucose and TG levels remain
similar in both groups, the concentrations of free fatty acids
are elevated in the knockdown mice. These observations are
consistent with impaired hepatic fatty acid oxidation when
BAF60a is knocked down. Gene-expression analysis revealed
that the mRNA levels of key enzymes in the FAO pathway—in-
cluding Acaa1b, Acox1, Acaa2, and Hadha—are significantly
lower in the livers of knockdown mice (Figure 7D). Interestingly,
the expression of Ech1 andAcadl remains similar in both groups,
suggesting that BAF60a is differentially required for the expres-
sion of FAO genes during fasting. The impairment of hepatic
fat oxidation in response to RNAi knockdown of BAF60a sug-
gests that this factor may be required for PPARa function. To as-Csess this, we transduced mice with control or BAF60a RNAi ad-
enoviruses followed by oral gavage of Wy14,643. As expected,
PPARa activation increases mRNA expression of FAO genes in
the control livers (Figure 7E), whereas this stimulatory effect is
significantly blunted in BAF60a-knockdown livers. Together,
these results indicate that BAF60a is required for physiological
regulation of hepatic fat oxidation during metabolic stresses
such as starvation.
DISCUSSION
The SWI/SNF complexes have been implicated in the regulation
of diverse biological processes, including embryogenesis, cell
cycle, differentiation, and tumorigenesis (Kwon and Wagner,
2007; Roberts and Orkin, 2004; Sudarsanam and Winston,
2000). While it has been recognized that the SWI/SNF com-
plexes can stimulate or inhibit the transcription of their target
genes, how they are targeted to specific chromatin loci remains
poorly understood. Several subunits of the SWI/SNF complexes
physically interact with transcription factors (Simone, 2006),
which are postulated to link chromatin remodeling to specific
biological functions. Using a genome-wide coactivation screen,
here we identified BAF60a as a factor that links the SWI/SNF
complexes to transcriptional coactivator PGC-1a and revealed
a role for BAF60a in hepatic lipid metabolism. Adenoviral-medi-
ated expression of BAF60a stimulates the entire program of
peroxisomal and mitochondrial fat oxidation and lowers liver
triglyceride content in mouse models of hepatic steatosis. Fur-
thermore, BAF60a is required for the activation of hepatic fat
oxidation during fasting.
The PGC-1 coactivators have emerged as versatile regulators
of energy metabolism and diverse biological processes. Using
high-throughput transfection and reporter gene assays, we
were able to interrogate this coactivator network with high sen-
sitivity and coverage. Because of the stringent criteria (10-fold
coactivation and coIP assays) that we used in our screen, several
factors known to interact with PGC-1a (myocytes enhancer fac-
tor 2c [MEF2c] and glucocorticoid receptor [GR], for example)
scored negative in this study. In the case of GR, the absence
of ligand in our initial screen may contribute to its weak coactiva-
tion by PGC-1a. In addition to known transcriptional partners for
PGC-1a,our analyses revealed a signature of the PGC-1a tran-
scriptional network that includes nuclear receptors, zinc-finger
proteins, as well as factors involved in different aspects of chro-
matin biology. This quantitative assay of individual TF activity
can be applied to globally identify the nuclear targets of meta-
bolic signaling pathways.
Several lines of evidence link BAF60a to the PPARa pathway.
BAF60a and PPARa share a large number of target genes in-
volved in peroxisomal and mitochondrial fat-oxidation path-
ways. Pharmacological activation of PPARa by Wy14,643 aug-
ments the induction of FAO genes by BAF60a. In addition, the
transcriptional function of BAF60a is significantly impaired in
PPARa-null hepatocytes. Despite this, BAF60a is still capable
of activating the expression of FAO genes in the absence of
PPARa, suggesting that both PPARa-dependent and PPARa-in-
dependent pathways mediate the metabolic effects of BAF60a
on hepatic fat oxidation (Figure 7F). At the molecular level,
BAF60a is recruited to PPARa-binding sites on the FAO-geneell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Inc. 113
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(A) Immunoblots of liver nuclear extracts from mice transduced with control (Ad-Scrb) or BAF60a RNAi (Ad-RNAi) adenoviruses.
(B) Liver morphology and histological staining of liver sections in transduced mice. Mice were subjected to 40 hr fasting before metabolic measurements and
gene-expression analysis.
(C) Hepatic TG, plasma lipid, and glucose concentrations in mice transduced with control (filled) or BAF60a RNAi (open) adenoviruses.
(D) qPCR analysis of hepatic gene expression in mice transduced with control (filled) or BAF60a RNAi (open) adenoviruses. Data in (C and D) represent mean ±
SEM (n = 4); *p < 0.05.
(E) qPCR analysis of hepatic gene expression in mice transduced with control or BAF60a RNAi adenoviruses followed by oral gavage with vehicle (open) or
300 mg Wy14,643 (filled). Data represent mean ± SD; *p < 0.05.
(F) Schematic model of the regulation of hepatic FAO genes by BAF60a and its associated SWI/SNF complexes. Note the nutritional regulation of BAF60a
recruitment to FAO genes through PPARa and other transcription factors.promoters in a PGC-1a-dependent manner. Given that PGC-1a
interacts with PPARa and BAF60a through different domains,
these data strongly suggest that PGC-1a promotes the forma-
tion of a transcriptional complex involving all three factors in
the proximity of FAO gene promoters.
While the induction of FAO genes by BAF60a is significantly
blunted in PGC-1a-null hepatocytes, the transcriptional effect
of BAF60a is not completely abolished in the absence of PGC-
1a. PGC-1b interacts with BAF60a in coIP studies (data not
shown) and may compensate for the loss of PGC-1a. Alterna-
tively, BAF60a may be recruited to the FAO gene promoters
through its direct interaction with PPARa. In fact, BAF60a binds
to the N terminus of PPARa in a ligand-independent manner,
suggesting that PGC-1a and BAF60a may interact with PPARa114 Cell Metabolism 8, 105–117, August 6, 2008 ª2008 Elsevier Incthrough a different binding surface. Perhaps the most interesting
observation from these studies is that although the levels of
BAF60a mRNA and protein remain largely unchanged in re-
sponse to fasting, its recruitment to the promoters of FAO genes
is significantly increased during starvation. While increased
PGC-1a expression contributes to BAF60a association with
chromatin, BAF60a itself may also be directly modulated by
nutritional signals at the posttranslational levels. In addition, be-
cause PGC-1a interacts with other chromatin-remodeling pro-
teins, we cannot rule out the possibility that PGC-1amay gener-
ate permissive environment that facilitates the association of
BAF60a with chromatin. Lipin 1, a gene mutated in the fatty liver
dystrophy mice, has been shown to participate in the formation
of PPARa/PGC-1a transcriptional complex (Finck et al., 2006;.
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tional activity of BAF60a, particularly in the context of FAO
gene expression, remains unknown.
Hepatic steatosis results from an imbalance of fat availability
and the ability of the liver to catabolize and/or secrete lipopro-
teins. Adenoviral-mediated expression of BAF60a ameliorates
hepatic steatosis in diet-induced obese and ob/ob mouse
livers. The decrease in hepatic TG content is accompanied by
the induction of FAO genes, suggesting that activation of the
BAF60a pathway is sufficient to alter the balance of hepatic
lipid metabolism through promoting fat oxidation. Interestingly,
we did not observe an increase of circulating ketone bodies in
BAF60a-transduced mice. This may be due to rapid clearance
of ketone bodies and/or complete oxidation of lipids in the liver.
RNAi knockdown of BAF60a impairs fat oxidation and leads
to hepatic steatosis following starvation, implicating BAF60a
as an essential factor for the activation of FAO genes during
fasting. Together, BAF60a defines a critical link between the
SWI/SNF chromatin-remodeling complexes and hepatic lipid
metabolism.
EXPERIMENTAL PROCEDURES
TFORC and Coactivation Screen
TFORC was obtained by arraying individual TF entry clones from the Human
ORFeome v3.1 onto 96 well plates. These entry clones were subsequently
transferred to a GalDBD destination vector using LR recombinase to generate
Gal-TF fusion plasmids (Invitrogen). For coactivation assay, BOSC cells
seeded in 96 well plates were transiently transfected with UAS-luciferase re-
porter (10 ng) and GAL-TF plasmids (10–20 ng) in the presence of vector or
pcDNA3 Flag-PGC-1a (100 ng) using Lipofectamine and Plus Reagent. Lucif-
erase activity was measured 30 hr after transfection.
CoIP Assay
Individual TF was cloned into a Gateway destination vector to generate N-
terminal Myc fusion proteins. These plasmids were cotransfected into BOSC
cells with either pcDNA3 vector or pcDNA3 Flag-PGC-1a. Immunoprecipitated
protein complexes and lysates were analyzed by immunoblotting using Myc
and Flag antibodies (Sigma). For interaction between PGC-1a and endoge-
nous SWI/SNF subunits, BOSC cells were transiently transfectedwith pcDNA3
vector or Flag-PGC-1a for 40 hr. Total lysates or immunoprecipitated proteins
were analyzed by immunoblotting using antibodies against BRG-1 (Santa Cruz
Biotech), BAF60a (BD Biosciences), or BAF53a (Proteintech Group). For
in vitro protein interaction assay, similar amounts of GST fusion proteins
were used in the binding assay in the presence of in vitro transcribed and trans-
lated Flag-tagged proteins generated using TNT-coupled system (Promega).
The precipitated proteins were analyzed by immunoblotting.
Primary Hepatocyte Studies
The maintenance and adenoviral transduction of primary hepatocytes was
performed as previously described (Liu et al., 2007). Total RNA was isolated
using Trizol reagents 48 hr following transduction, reverse transcribed, and an-
alyzed by qPCR using primers listed in Table S5. Primers for ribosomal protein
36B4 were included for normalization. For the measurements of fatty acid ox-
idation, transduced hepatocytes were incubated with 800 ml (9,10(n)-3H) pal-
mitic acid (Perkin-Elmer) bound to fatty acid-free BSA (final concentration,
125 mM; palmitate to BSA 1:1) in the presence of 1.0 mM carnitine for 2 hr.
The release of 3H2O was measured using a scintillation counter following tri-
chloroacetic-acid precipitation and ion-exchange chromatography, as previ-
ously described (Finck et al., 2006). Total radioactivity was normalized to pro-
tein content for the calculation of FAO rate. For the measurements of TG
secretion, hepatocytes were incubated with [1,2,3-3H] glycerol (5.0 mCi/ml)
for 3 hr. TG in the medium was extracted for scintillation counting followed
by normalization to cellular protein content.CChIP Assay
ChIP was performed essentially as described by Upstate Biotechnology.
Chromatin lysateswere prepared fromH2.35 hepatoma cells after crosslinking
with 1% formaldehyde followed by brief sonication. For chromatin lysates from
mouse livers, liver nuclei were isolated as previously described (Calfee-Mason
et al., 2002) and then crosslinked in 1% formaldehyde for 10 min followed by
sonication. After precleared with Protein-G agarose beads, chromatin lysates
were immunoprecipitated using antibodies against BAF60a, acetylated his-
tone H3 (Upstate Biotechnology), PGC-1a (Santa Cruz Biotech), PPARa
(Chemicon), or normal mouse IgG in the presence of BSA and salmon sperm
DNA. Beads were extensively washed before reverse crosslinking. DNA was
purified using a PCR Purification Kit (QIAGEN) and subsequently analyzed
by PCR using primers surrounding PPRE on Acox1, Acaa1b, and Hadha
promoters (Lemay and Hwang, 2006; Nicolas-Frances et al., 2000; Tugwood
et al., 1992) (Table S5).
In Vivo Adenoviral Transduction and Metabolic Analyses
C57/Bl6J male mice were fed a high-fat diet (D12492, Research Diets) for 10
weeks to induce obesity. GFP or BAF60a adenoviruses were administered
into mice through tail-vein injection (0.15 optical density per mouse), as previ-
ously described (Lin et al., 2005b). Liver triglycerides and plasma lipid concen-
trations weremeasured 5–7 days following tail-vein injection using commercial
assay kits (Sigma, Wako Diagnostics). Frozen or paraffin-embedded sections
were prepared for Oil Red O and H&E staining, respectively.
For VLDL secretion assay, transducedmice were injected with a single dose
of tyloxapol (500 mg/kg) through tail vein. Tail blood was sampled 30, 60, and
90 min after injection and assayed for TG concentrations.
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